346 related articles for article (PubMed ID: 22724067)
1. Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
Borst P
Open Biol; 2012 May; 2(5):120066. PubMed ID: 22724067
[TBL] [Abstract][Full Text] [Related]
2. Cancer drug resistance: an evolving paradigm.
Holohan C; Van Schaeybroeck S; Longley DB; Johnston PG
Nat Rev Cancer; 2013 Oct; 13(10):714-26. PubMed ID: 24060863
[TBL] [Abstract][Full Text] [Related]
3. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
[TBL] [Abstract][Full Text] [Related]
4. Transporter molecules in multidrug resistance.
Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
[No Abstract] [Full Text] [Related]
5. Novel mechanisms of drug resistance in leukemia.
Ross DD
Leukemia; 2000 Mar; 14(3):467-73. PubMed ID: 10720143
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance in gliomas.
Lu C; Shervington A
Mol Cell Biochem; 2008 May; 312(1-2):71-80. PubMed ID: 18259841
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of cellular resistance to cancer chemotherapy.
Krishan A; Arya P
Hematol Oncol Clin North Am; 2002 Apr; 16(2):357-72, vi. PubMed ID: 12094476
[TBL] [Abstract][Full Text] [Related]
9. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
10. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
11. Both P-gp and MRP contribute to drug resistance in AML.
Legrand O; Simonin G; Zittoun R; Marie JP
Leukemia; 1998 Aug; 12(8):1327-8. PubMed ID: 9697893
[No Abstract] [Full Text] [Related]
12. Drug resistance in the mouse cancer clinic.
Rottenberg S; Borst P
Drug Resist Updat; 2012; 15(1-2):81-9. PubMed ID: 22335919
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib antagonizes ABC transporters in acute myeloid leukemia.
Lainey E; Sébert M; Thépot S; Scoazec M; Bouteloup C; Leroy C; De Botton S; Galluzzi L; Fenaux P; Kroemer G
Cell Cycle; 2012 Nov; 11(21):4079-92. PubMed ID: 23095522
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Germann UA
Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
[No Abstract] [Full Text] [Related]
16. Cancer stem cells: A product of clonal evolution?
van Niekerk G; Davids LM; Hattingh SM; Engelbrecht AM
Int J Cancer; 2017 Mar; 140(5):993-999. PubMed ID: 27676693
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Aragon-Ching JB
Anticancer Agents Med Chem; 2010 Oct; 10(8):582. PubMed ID: 21244347
[No Abstract] [Full Text] [Related]
18. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
Chen Y; Bieber MM; Teng NN
Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
[TBL] [Abstract][Full Text] [Related]
19. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
20. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.
Twentyman PR; Versantvoort CH
Eur J Cancer; 1996 Jun; 32A(6):1002-9. PubMed ID: 8763341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
